Dow Up 0.48% Nasdaq Up 0.43%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
14.83 Aug 19, 4:00PM EDT
Prev Close:14.83
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:31.50
Beta:-0.67
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:N/A - N/A
52wk Range:12.61 - 29.79
Volume:0
Avg Vol (3m):192,703
Market Cap:342.71M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RPRX

Comparison

Symbol% ChgMkt Cap
RPRX 0.00%342.71M
ABT63.97B
ACT58.95B
AUXL904.63M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.52
Quarterly EPS Est (Sep-14) :-0.38
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):0.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback